Skip to main content

Advertisement

SpringerLink
Log in

A call to action: unified clinical practice guidelines for oncofertility care

  • Fertility Preservation
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

By 2030, WHO estimates that 1.4 million reproductive-aged women will be diagnosed with cancer annually. Fortunately, cancer is no longer considered an incurable disease in many cases. From 2008–2014, 85% of women under the age of 45 years diagnosed with cancer survived. This increase in survival rate has shifted attention from focusing exclusively on preserving life to focusing on preserving quality of life after treatment. One aspect of this is preserving the ability to have a biological family. Oncofertility, the field that bridges oncology and reproductive endocrinology with the goal of preserving fertility, offers these patients hope. Though it is clear that ASCO and ASRM recognize the importance of fertility preservation as an aspect of comprehensive oncology care, there are not yet unified guidelines for oncologists and fertility specialists for treating oncofertility patients. First, we identify the need for reproductive counseling prior to cancer treatment, as many patients report that their fertility preservation concerns are not addressed adequately. We then delineate multi-modal fertility preservation options that are available and appropriate for different patients with corresponding outcomes using different treatments. We discuss the unique challenges and considerations, including ethical dilemmas, for delivering timely and comprehensive care specifically for oncofertility patients. Finally, we address the multidisciplinary team that includes oncologists, reproductive endocrinologists, surgeons as well as their staff, nurses, genetic counselors, mental health professionals, and more. Since oncofertility patient care requires the coordination of both physician teams, one set of unified guidelines will greatly improve quality of care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anazodo A, Laws P, Logan S, Saunders C, Travaglia J, Gerstl B, et al. How can we improve oncofertility care for patients? A systematic scoping review of current international practice and models of care. Hum Reprod Update. 2019;25(2):159–79.

    Article  PubMed  Google Scholar 

  2. Flink DM, Sheeder J, Kondapalli LA. A Review of the Oncology Patient's Challenges for Utilizing Fertility Preservation Services. J Adolesc Young Adult Oncol. 2017;6(1):31–44.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cancer Facts & Figures 2018 - American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf.

  4. Noone AM, Howlader N, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website, April 2018.

  5. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS. Fertility Preservation in Patients with Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1994–2001.

    Article  PubMed  Google Scholar 

  6. Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112:1022–33.

    Article  Google Scholar 

  7. Letourneau JM, Ebbel EE, Katz PP, Oktay KH, McCulloch CE, Ai WZ. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer. 2011;118(7):1933–9.

    Article  PubMed  Google Scholar 

  8. Schumacher BL, Grover N, Mesen T, Steiner A, Mersereau J. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy. Hum Reprod. 2017;32(10):2049–55.

    Article  Google Scholar 

  9. Mahajan N. Fertility preservation in female cancer patients: An overview. J Hum Reprod Sci. 2015;8(1):3–13.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Koert E, Daniluk JC. When time runs out: Reconciling permanent childlessness after delayed childbearing. J Reprod Infant Psychol. 2017;35(4):342–52.

    Article  PubMed  Google Scholar 

  11. Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M. Web-Based Survey of Fertility Issues in Young Women With Breast Cancer. J Clin Oncol. 2004;22(20):4174–83.

    Article  PubMed  Google Scholar 

  12. Henes JC, Henes M, von Wolff M, Schmalzing M, Kotter I, Lawrenz B. Fertility preservation in women with vasculitis: Experiences from the FertiPROTEKT network. Clin Exp Rheumatol. 2012;30(1).

  13. Henes M, Henes JC, Neunhoeffer E, von Wolff M, Schmalzing M, Kötter I, et al. Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy: experiences from the FertiProtekt network. Lupus. 2012;21(9):953–8.

    Article  CAS  PubMed  Google Scholar 

  14. Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA. 2017;317(23):2402–16.

    Article  CAS  PubMed  Google Scholar 

  15. Vuković P, Peccatori FA, Massarotti C, Miralles MS, Beketić-Orešković L, Lambertini M. Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants. Crit Rev Oncol Hematol. 2020;157:103201.

    Article  PubMed  Google Scholar 

  16. Oktay K, Kim JY, Barad D, Babayev SN. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol. 2010;28(2):240–4.

    Article  CAS  PubMed  Google Scholar 

  17. Oktay K, Turan V, Titus S, Stobezki R, Liu L. BRCA Mutations, DNA Repair Deficiency, and Ovarian Aging. Biol Reprod. 2015;93(3):67.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Turan V, Oktay K. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging. Hum Reprod Update. 2020;26(1):43–57.

    Article  CAS  PubMed  Google Scholar 

  19. Depalo R, Falagario D, Masciandaro P, Nardelli C, Vacca MP, Capuano P, et al. Fertility preservation in males with cancer: 16-year monocentric experience of sperm banking and post-thaw reproductive outcomes. Ther Adv Med Oncol. 2016;8(6):412–20.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Schrader M, Muller M, Sofikitis N, et al. “Onco-TESE”: testicular sperm extraction in azoospermic cancer patients before chemotherapy—new guidelines? Urology. 2003;61(2):422–5.

    Article  Google Scholar 

  21. Furuhashi K, Ishikawa T, Hashimoto H, Yamada S, Ogata S, Mizusawa Y. Onco-testicular sperm extraction: testicular sperm extraction in azoospermic and very severely oligozoospermic cancer patients. Andrologia. 2013;45:107–10.

    Article  CAS  PubMed  Google Scholar 

  22. Pinelli S, Basile S. Fertility preservation: current and future perspectives for oncologic patients at risk for iatrogenic premature ovarian insufficiency. Biomed Res Int. 2018;2018:1–9.

    Article  Google Scholar 

  23. Lambertini M, Peccatori FA, Demeestere I, Amant F, Wyns C, Stukenborg JB. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2020;31(12):1664–78.

    Article  CAS  PubMed  Google Scholar 

  24. Pacheco F, Oktay K. Current success and efficiency of autologous ovarian transplantation: a meta-analysis. Reprod Sci. 2017;24(8).

  25. Dolmans MM, Luyckx V, Donnez J, Andersen CY, Greve T. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013;99(6):1514–22.

    Article  PubMed  Google Scholar 

  26. Kyono K, Doshida M, Toya M, Sato Y, Akahira J, Sasano H. Potential indications for ovarian autotransplantation based on the analysis of 5,571 autopsy findings of females under the age of 40 in Japan. Fertil Steril. 2010;93(7):2429–30.

    Article  PubMed  Google Scholar 

  27. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008;23(5):1007–13.

    Article  PubMed  Google Scholar 

  28. Shapira M, Raanani H, Barshak I, Amariglio N, Derech-Haim S, Marciano MN. First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination. Fertil Steril. 2018;109(1):48–53.

    Article  PubMed  Google Scholar 

  29. The Oncofertility Consortium. Installing oncofertility programs for common cancers in optimum resource settings (Repro-Can-OPEN Study Part II): a committee opinion. J Assist Reprod Genet. 2021;38(1):163–76.

    Article  Google Scholar 

  30. Fauser BCJM. Patient-tailored ovarian stimulation for in vitro fertilization. Fertil Steril. 2017;108(4):585–91.

    Article  PubMed  Google Scholar 

  31. Jungheim ES, Meyer MF, Broughton DE. Best practices for controlled ovarian stimulation in IVF. Semin Reprod Med. 2015;33(2):77–82.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Moravek MB, Confinno R, Smith KN, et al. Long term outcomes in cancer patients who did or did not pursue fertility preservation. Fertil Steril. 2018;109(2):349–55.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Robertson AD, Missmer SA, Ginsburg ES. Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy. Fertil Steril. 2011;95(2):588–91.

    Article  PubMed  Google Scholar 

  34. Zhang J, Grifo JA, Del Priore G. Gestational carrier pregnancy with oocytes obtained during surgery for stage IIIc ovarian cancer after controlled ovarian stimulation. Fertil Steril. 2005;83(5):1547.e15–7.

    Article  Google Scholar 

  35. Juretzka MM, O’Hanlan KA, Katz SL, El-Danasouri I, Westphal LM. Fertil Steril. 2005;83(4):1041.e5–7.

    Article  Google Scholar 

  36. Krychman ML, King T. Pregnancy after breast cancer: a case study resolving the reproductive challenge with a gestational surrogate. Breast J. 2006;12(4):363–5.

    Article  PubMed  Google Scholar 

  37. Cobo A, Coello A, Remohí J, Serrano J, de Los Santos JM, Meseguer M. Effect of oocyte vitrification on embryo quality: time-lapse analysis and morphokinetic evaluation. Fertil Steril. 2017;108(3).

  38. Kushnir VA, Barad DH, Albertini DF, Darmon SK, Gleicher N. Outcomes of fresh and cryopreserved oocyte donation. JAMA. 2015;314(6):623.

    Article  CAS  PubMed  Google Scholar 

  39. O’Flynn N. Assessment and treatment for people with fertility problems: NICE guideline. Br J Gen Pract. 2014;64(618):50–1.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Practice Committees of the American Society of Reproductive Medicine. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2012;99(1):37–43.

    Google Scholar 

  41. Dolmans MM, Demylle D, Martinez-Madrid B, Donnez J. Efficacy of in vitro fertilization after chemotherapy. Fertil Steril. 2005;83(4):897–901.

    Article  PubMed  Google Scholar 

  42. Roness H, Kashi O, Meirow D. Prevention of chemotherapy-induced ovarian damage. Fertil Steril. 2016;105(1):20–9.

    Article  CAS  PubMed  Google Scholar 

  43. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–10.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Peccatori FA, Azim HA, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(6):160–70.

    Article  Google Scholar 

  45. Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA Jr, Ugolini D, et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol. 2015;26(12):2408–19.

    Article  CAS  PubMed  Google Scholar 

  46. Practice Committee ISFP, Kim SS, Donnez J, Barri P, et al. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet. 2012;29(6):465–8.

    Article  Google Scholar 

  47. Dolinko AV, Farland LV, Missmer SA, Srouji SS, Racowsky C, Ginsburg ES. Responses to fertility treatment among patients with cancer: a retrospective cohort study. Fertil Res Pract. 2018;4:3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Antinori M, Licata E, Dani G, Cerusico F, Versaci C, Antinori S. Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod BioMed Online. 2007;14(1):72–9.

    Article  PubMed  Google Scholar 

  49. Dolmans MM, de Ouderaen SH, Demylle D, Pirard C. Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment. J Assist Reprod Genet. 2015;32(8):1233–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Cobo A, García-Velasco J, Domingo J, Pellicer A, Remohí J. Elective and onco-fertility preservation: factors related to IVF outcomes. Hum Reprod. 2018:1–10.

  51. Losk K, Vaz-Luis I, Camuso K, Batista R, Lloyd M, Tukenmez M, et al. Factors associated with delays in chemotherapy initiation among patients with breast cancer at a comprehensive cancer center. J Natl Compr Cancer Netw. 2016;14(12):1519–26.

    Article  Google Scholar 

  52. Chavez-Macgregor M, Clarke CA, Lichtensztajn DY, Giordano SH. Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol. 2016;2(3).

  53. Reddy J, Oktay K. Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. Fertil Steril. 2012;98(6):1363–9.

    Article  CAS  PubMed  Google Scholar 

  54. Azim AA, Constantini-Ferrando M, Oktay K. Safety of ovarian stimulation with letrozole and gonadotropins in breast cancer patients undergoing embryo or oocyte cryopreservation: a prospective controlled study. J Clin Oncol. 2008;26(16).

  55. Cavagna F, Pontes A, Cavagna M, Dzik A, Donadio NF, Portela R, et al. A specific controlled ovarian stimulation (COS) protocol for fertility preservation in women with breast cancer undergoing neoadjuvant chemotherapy. Contemp Oncol (Pozn). 2017;21(4):290–4.

    Google Scholar 

  56. Sporn MB, Lippman SM. Agents for Chemoprevention and Their Mechanism of Action. Holland-Frei Cancer Med. 2003;6.

  57. Mn EG, Ae M, Ma F. Letrozole versus tamoxifen in treatment of clomiphene citrate resistant polycystic ovarian syndrome. Enliven. 2014;01(02).

  58. Seyedoshohadaei F, Zandvakily F, Shahgeibi S. Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation. Iran J Reprod Med. 2012;10(6):531–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Coyne K, Purdy M, O’Leary K, Yaklic JL, Rindheim SR, Appiah LA. Challenges and considerations in optimizing ovarian stimulation protocols in oncofertility patients. Front Public Health. 2014;2:246.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347–53.

    Article  CAS  PubMed  Google Scholar 

  61. Oktay K, Türkçüoğlu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod BioMed Online. 2010;20(6):783–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Pereira N, Kelly AG, Stone LD, Witzke JD, Lekovich JP, Elias RT, et al. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation. Fertil Steril. 2017;108(3):532–8.

    Article  CAS  PubMed  Google Scholar 

  63. Thorne J, Loza A, Kaye L, Nulsen J, Benadiva C, Grow D. Euploidy rates between cycles triggered with gonadotropin-releasing hormone agonist and human chorionic gonadotropin. Fertil Steril. 2019;112(2):258–65.

    Article  CAS  PubMed  Google Scholar 

  64. Dessole S, Rubattu G, Ambrosini G, Miele M, Nardelli GB, Cherchi PL. Blood loss following noncomplicated transvaginal oocyte retrieval for in vitro fertilization. Fertil Steril. 2001;76(1):205–6.

    Article  CAS  PubMed  Google Scholar 

  65. Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23:727–36.

    Article  PubMed  Google Scholar 

  66. Freeman AH, Barrie A, Lyon L, Littell RD, Garcia C, Conell C, et al. Venous thromboembolism following minimally invasive surgery among women with endometrial cancer. Gynecol Oncol. 2016;142:267–72.

    Article  PubMed  Google Scholar 

  67. Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27(35):5952–7.

    Article  PubMed  Google Scholar 

  68. Forman EJ, Anders CK, Behera MA. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril. 2008;90:S267–8.

    Article  Google Scholar 

  69. Woodruff TK, Ataman-Millhouse L, Acharya KS, Almeida-Santos T, Anazodo A, Anderson RA, et al. A View from the past into our collective future: the oncofertility consortium vision statement. J Assist Reprod Genet. 2021;38(1):3–15.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Domar AD, Zuttermeister PC, Friedman R. The psychological impact of infertility: a comparison with patients with other medical conditions. J Psychosom Obstet Gynaecol. 1993;14:45–52.

    PubMed  Google Scholar 

  71. Carter J, Rowland K, Chi D, Brown C, Abu-Rustum N, Castiel M, et al. Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecol Oncol. 2005;97(1):90–5.

    Article  PubMed  Google Scholar 

  72. Ethics Committee of the American Society of Reproductive Medicine. Posthumous collection and use of reproductive tissue: a committee opinion. Fertil Steril. 2013;99(7):1842–5.

    Article  Google Scholar 

  73. Ethics Committee of the American Society of Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: an ethics committee opinion. Fertil Steril. 2018;110(3):380–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vios Fertility Institute, 1455 N Milwaukee Ave, Chicago, IL, 60622, USA

    Jacqueline Sehring, Anisa Hussain, Lauren Grimm, Elisabeth Rosen, Jody Esguerra, Erica Louden, Angeline Beltsos & Roohi Jeelani

  2. Advocate Lutheran General Hospital, Park Ridge, IL, USA

    Karine Matevossian

Authors
  1. Jacqueline Sehring
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anisa Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lauren Grimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elisabeth Rosen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jody Esguerra
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Karine Matevossian
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Erica Louden
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Angeline Beltsos
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Roohi Jeelani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacqueline Sehring.

Ethics declarations

Conflict of interest

All authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sehring, J., Hussain, A., Grimm, L. et al. A call to action: unified clinical practice guidelines for oncofertility care. J Assist Reprod Genet 38, 1745–1754 (2021). https://doi.org/10.1007/s10815-021-02142-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-021-02142-z

Keywords

Search

Navigation